The Ethical Pharmaceutical Co. Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 17-07-2024
- Paid Up Capital ₹ 0.81 M
as on 17-07-2024
- Company Age 43 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.74 Cr
as on 17-07-2024
- Revenue -64.76%
(FY 2023)
- Profit -87.00%
(FY 2023)
- Ebitda 22.70%
(FY 2023)
- Net Worth 1.01%
(FY 2023)
- Total Assets 0.99%
(FY 2023)
About The Ethical Pharmaceutical Co.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.81 M.
The company has closed loans amounting to ₹1.74 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kamlesh Vohra and Bhupendra Sangani serve as directors at the Company.
- CIN/LLPIN
U24200MH1981PTC025411
- Company No.
025411
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 1981
- Date of AGM
13 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at The Ethical Pharmaceutical Co.?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhupendra Sangani  | Managing Director | 12-Oct-1981 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamlesh Vohra | Director | 12-Oct-1981 | Current |
Financial Performance of The Ethical Pharmaceutical Co..
The Ethical Pharmaceutical Co. Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 64.76% decrease. The company also saw a substantial fall in profitability, with a 87% decrease in profit. The company's net worth moved up by a moderate rise of 1.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of The Ethical Pharmaceutical Co.?
In 2023, The Ethical Pharmaceutical Co. had a promoter holding of 0.05% and a public holding of 99.95%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Galentic Pharma India Pvt LtdActive 32 years 9 monthsKamlesh Vohra and Bhupendra Sangani are mutual person
- Apollo Business Technologies Private LimitedActive 19 years 4 months
Kamlesh Vohra is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Maharashtra Creation Date: 05 Feb 2009 | ₹1.14 M | Satisfied |
Bank Of Maharashtra Creation Date: 10 Mar 1999 | ₹0.80 M | Satisfied |
Bank Of Maharashtra Creation Date: 05 Mar 1999 | ₹4.95 M | Satisfied |
How Many Employees Work at The Ethical Pharmaceutical Co.?
Unlock and access historical data on people associated with The Ethical Pharmaceutical Co., such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of The Ethical Pharmaceutical Co., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped The Ethical Pharmaceutical Co.'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
